Literature DB >> 26435917

Total gadolinium tissue deposition and skin structural findings following the administration of structurally different gadolinium chelates in healthy and ovariectomized female rats.

Yì-Xiáng J Wáng1, Joseph Schroeder1, Heiko Siegmund1, Jean-Marc Idée1, Nathalie Fretellier1, Gaëlle Jestin-Mayer1, Cecile Factor1, Min Deng1, Wei Kang1, Sameh K Morcos1.   

Abstract

OBJECTIVE: To assess the retention of gadolinium (Gd) in skin, liver, and bone following gadodiamide or gadoteric acid administration.
METHODS: Gd was measured in skin, liver and femur bone in female rats 10 weeks after administration of 17.5 mmol Gd/kg over 5 days of Gd agents. Rat skin microscopy, energy filtering transmission electron microscopy and elemental analysis were performed, and repeated after receiving the same dosage of gadodiamide in rats with osteoporosis induced with bilateral ovariectomy (OVX). The OVX was performed 60 days after the last injection of gadodiamide and animals sacrificed 3 weeks later.
RESULTS: Gd concentration was 180-fold higher in the skin, 25-fold higher in the femur, and 30-fold higher in the liver in rats received gadodiamide than rats received gadoteric acid. The retention of Gd in the skin with gadodiamide was associated with an increase in dermal cellularity, and Gd encrustation of collagen fibers and deposition inside the fibroblasts and other cells. No differences in Gd concentration in liver, skin, and femur were observed between rats receiving gadodiamide with or without OVX.
CONCLUSIONS: Gd tissue retention with gadodiamide was higher than gadoteric acid. Tissues Gd deposition did not alter following gadodiamide administration to ovariectomized rats.

Entities:  

Keywords:  Gadolinium (Gd); bone deposition; osteoporosis; skin; ultrastructural

Year:  2015        PMID: 26435917      PMCID: PMC4559982          DOI: 10.3978/j.issn.2223-4292.2015.05.03

Source DB:  PubMed          Journal:  Quant Imaging Med Surg        ISSN: 2223-4306


  36 in total

1.  The biodistribution of [153Gd]Gd-labeled magnetic resonance contrast agents in a transgenic mouse model of renal failure differs greatly from control mice.

Authors:  Thaddeus J Wadas; Christopher D Sherman; Jeffrey H Miner; James R Duncan; Carolyn J Anderson
Journal:  Magn Reson Med       Date:  2010-11       Impact factor: 4.668

2.  Gd-DOTA: characterization of a new paramagnetic complex.

Authors:  J C Bousquet; S Saini; D D Stark; P F Hahn; M Nigam; J Wittenberg; J T Ferrucci
Journal:  Radiology       Date:  1988-03       Impact factor: 11.105

3.  Gadolinium chloride toxicity in the rat.

Authors:  A J Spencer; S A Wilson; J Batchelor; A Reid; J Rees; E Harpur
Journal:  Toxicol Pathol       Date:  1997 May-Jun       Impact factor: 1.902

Review 4.  Toxicological and cytophysiological aspects of lanthanides action.

Authors:  A Pałasz; P Czekaj
Journal:  Acta Biochim Pol       Date:  2000       Impact factor: 2.149

Review 5.  Bone resorption by osteoclasts.

Authors:  S L Teitelbaum
Journal:  Science       Date:  2000-09-01       Impact factor: 47.728

6.  Incorporation of excess gadolinium into human bone from medical contrast agents.

Authors:  Thomas H Darrah; Jennifer J Prutsman-Pfeiffer; Robert J Poreda; M Ellen Campbell; Peter V Hauschka; Robyn E Hannigan
Journal:  Metallomics       Date:  2009-09-16       Impact factor: 4.526

7.  Rat lumbar vertebrae bone densitometry using multidetector CT.

Authors:  Yi-Xiang J Wang; James F Griffith; Hua Zhou; Kai Chow Choi; Vivian W Y Hung; David K W Yeung; Ling Qin; Anil T Ahuja
Journal:  Eur Radiol       Date:  2008-10-29       Impact factor: 5.315

8.  Comparison of Gd(DTPA-BMA) (Omniscan) versus Gd(HP-DO3A) (ProHance) relative to gadolinium retention in human bone tissue by inductively coupled plasma mass spectroscopy.

Authors:  Gregory W White; Wendell A Gibby; Michael F Tweedle
Journal:  Invest Radiol       Date:  2006-03       Impact factor: 6.016

9.  Preclinical investigation to compare different gadolinium-based contrast agents regarding their propensity to release gadolinium in vivo and to trigger nephrogenic systemic fibrosis-like lesions.

Authors:  Martin A Sieber; Philipp Lengsfeld; Thomas Frenzel; Sven Golfier; Heribert Schmitt-Willich; Fred Siegmund; Jakob Walter; Hanns-Joachim Weinmann; Hubertus Pietsch
Journal:  Eur Radiol       Date:  2008-06-11       Impact factor: 5.315

10.  Long-term retention of gadolinium in the skin of rodents following the administration of gadolinium-based contrast agents.

Authors:  Hubertus Pietsch; Philipp Lengsfeld; Gregor Jost; Thomas Frenzel; Joachim Hütter; Martin A Sieber
Journal:  Eur Radiol       Date:  2009-01-24       Impact factor: 5.315

View more
  14 in total

Review 1.  Gadolinium retention in the body: what we know and what we can do.

Authors:  Enrico Tedeschi; Ferdinando Caranci; Flavio Giordano; Valentina Angelini; Sirio Cocozza; Arturo Brunetti
Journal:  Radiol Med       Date:  2017-03-30       Impact factor: 3.469

Review 2.  A comprehensive literatures update of clinical researches of superparamagnetic resonance iron oxide nanoparticles for magnetic resonance imaging.

Authors:  Yì Xiáng J Wáng; Jean-Marc Idée
Journal:  Quant Imaging Med Surg       Date:  2017-02

3.  Gadolinium Chelate Safety in Pregnancy: Barely Detectable Gadolinium Levels in the Juvenile Nonhuman Primate after in Utero Exposure.

Authors:  Joao Prola-Netto; Mark Woods; Victoria H J Roberts; Elinor L Sullivan; Christina Ann Miller; Antonio E Frias; Karen Y Oh
Journal:  Radiology       Date:  2017-09-04       Impact factor: 11.105

4.  An NMR relaxometry approach for quantitative investigation of the transchelation of gadolinium ions from GBCAs to a competing macromolecular chelator.

Authors:  Patrick Werner; Matthias Taupitz; Leif Schröder; Patrick Schuenke
Journal:  Sci Rep       Date:  2021-11-05       Impact factor: 4.379

5.  Albumin-based nanoparticles as contrast medium for MRI: vascular imaging, tissue and cell interactions, and pharmacokinetics of second-generation nanoparticles.

Authors:  E A Wallnöfer; G C Thurner; C Kremser; H Talasz; M M Stollenwerk; A Helbok; N Klammsteiner; K Albrecht-Schgoer; H Dietrich; W Jaschke; P Debbage
Journal:  Histochem Cell Biol       Date:  2020-10-11       Impact factor: 4.304

6.  Effects of gadolinium-based contrast agents on submandibular gland tissue in rats.

Authors:  Fatma Beyazal Celiker; Levent Tumkaya; Adnan Yilmaz; Zerrin Ozergin Coskun; Metin Celiker; Fatih Oghan; Tolga Mercantepe; Suat Terzi; Engin Dursun
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-03-31       Impact factor: 2.503

7.  Increased signal intensities in the dentate nucleus and globus pallidus on unenhanced T1-weighted images: evidence in children undergoing multiple gadolinium MRI exams.

Authors:  Houchun H Hu; Amber Pokorney; Richard B Towbin; Jeffrey H Miller
Journal:  Pediatr Radiol       Date:  2016-06-09

8.  Gadolinium distribution in kidney tissue determined and quantified by micro synchrotron X-ray fluorescence.

Authors:  Wolf Osterode; Gerald Falkenberg; Heinz Regele
Journal:  Biometals       Date:  2021-01-23       Impact factor: 2.949

Review 9.  Gadolinium-based contrast agent toxicity: a review of known and proposed mechanisms.

Authors:  Moshe Rogosnitzky; Stacy Branch
Journal:  Biometals       Date:  2016-04-06       Impact factor: 2.949

10.  Quantitative perfusion mapping with induced transient hypoxia using BOLD MRI.

Authors:  Chau Vu; Yaqiong Chai; Julie Coloigner; Aart J Nederveen; Matthew Borzage; Adam Bush; John C Wood
Journal:  Magn Reson Med       Date:  2020-07-27       Impact factor: 3.737

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.